PBS News Hour

Why the FDA approved a controversial Alzheimer's drug

The FDA on Monday approved the first new drug to treat Alzheimer's disease in nearly two decades. Federal health officials said it may help slow the brain-destroying disease's progression, but the approval goes against the agency's independent advisers who said the treatment wasn't effective in clinical trials. Pam Belluck, health reporter for The New York Times, joins Amna Nawaz to discuss.

Why the FDA approved a controversial Alzheimer's drug

6m

WETA Passport

Stream tens of thousands of hours of your PBS and local favorites with WETA Passport whenever and wherever you want. Catch up on a single episode or binge-watch full seasons before they air on TV.